Thermo Fisher will end manufacturing and lay off 205 staff at the former Brammer Bio gene therapy facility in Alachua, Florida. The closure of the Alachua plant is part of plans to consolidate Thermo Fisher’s viral vector services (VVS) division, part of the life sciences supplier contract development and manufacturing organization (CDMO) business. “We believe that leveraging our global network to provide multiple capabilities, including process development, analytical development, and clinical and commercial cGMP manufacturing, in one location will help…